Skip to content

Crinetics Pharmaceuticals CRNX Prepaid Expenses, Non-Current

Prepaid Expenses, Non-Current at other companies

KEE
Keel Infrastructure Corp. Common StockKEEL
$72.01M
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$24.82M
Paylocity logo
PaylocityPCTY
$8.59M+30.0%
Life360, Inc. logo
Life360, Inc.LIF
$44.93M+105%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$50.92M-8.4%
Popular logo
PopularBPOP
$24.98M+1.8%

Other financials

Income statement

See full
Revenue$10.7M+2,873%
Gross profit$10.5M+2,818%
Operating income-$140.4M-26.0%
Net income-$127.8M-32.1%
EPS (diluted)-$1.23-18.3%

Balance sheet

See full
Cash & equivalents$115.1M+20.1%
Total debt$47.9M-5.8%
Total equity$1.3B+2.1%
Total assets$1.4B+2.9%

Cash flow

See full
Operating cash flow-$124.7M-41.0%
CapEx$820.0K-33.8%
Free cash flow-$125.5M-40.0%

Valuation

See full
Market cap$3.78B+21.9%
Enterprise value$3.71B+21.5%
P/S209.3×-3,875×

Profitability

See full
Gross margin150%-15.6pp
Operating margin-3,020.3%-1,463pp
Net margin-2,747.2%-1,328pp
FCF margin-2,321.7%-1,122pp

Returns & leverage

See full
Return on equity-39.2%+14.5pp
Debt / equity0.0×
Current ratio18.6×-3.9×

Where this comes from

Reported directly by Crinetics Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent.

The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Crinetics Pharmaceuticals's prepaid expenses, non-current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Crinetics Pharmaceuticals's prepaid expenses, non-current?
Crinetics Pharmaceuticals (CRNX) reported prepaid expenses, non-current of $24.82M in Q1 2026.
What does prepaid expenses, non-current mean?
This represents payments made in advance for goods or services that will be received or utilized over a period exceeding twelve months. For a clinical-stage pharmaceutical company, this often includes long-term deposits for manufacturing capacity or multi-year research service agreements. It reflects the company's commitment of capital to secure future operational resources.